Graves' disease is an autoimmune disorder which affect thyroid gland. Graves' disease is the most common cause of hyperthyroidism and thyrotoxicosis. Understanding of disease pathophysiology, diagnostic and treatment strategies, and prevention of disease relapse are important for all clinicians especially internal medicine specialist to give optimal and comprehensive management for Graves' disease patients. This article highlights clinical points to treat Grave's disease patients from reviews and latest guidelines from American Thyroid Association (ATA), European Thyroid Association (ETA), and Japan Thyroid Association/ Japan Endocrine Society.
|Number of pages||6|
|Journal||Acta medica Indonesiana|
|Publication status||Published - 1 Apr 2018|
- American Thyroid Association (ATA)
- European Thyroid Association (ETA)
- Grave's disease
- Japan Thyroid Association/ Japan Endocrine Society